Abstract:ObjectivesTo develop and validate a clinical-radiomics model that incorporates radiomics signatures and pretreatment clinicopathological parameters to identify multimodality therapy candidates among patients with early-stage cervical cancer.MethodsBetween January 2017 and February 2021, 235 patients with IB1-IIA1 cervical cancer who underwent radical hysterectomy were enrolled and divided into training (n = 194, training:validation = 8:2) and testing (n = 41) sets according to surgical time. The radiomics features of each patient were extracted from preoperative sagittal T2-weighted images. Significance testing, Pearson correlation analysis, and Least Absolute Shrinkage and Selection Operator were used to select radiomic features associated with multimodality therapy administration. A clinical-radiomics model incorporating radiomics signature, age, 2018 Federation International of Gynecology and Obstetrics (FIGO) stage, menopausal status, and preoperative biopsy histological type was developed to identify multimodality therapy candidates. A clinical model and a clinical-conventional radiological model were also constructed. A nomogram and decision curve analysis were developed to facilitate clinical application.ResultsThe clinical-radiomics model showed good predictive performance, with an area under the curve, sensitivity, and specificity in the testing set of 0.885 (95% confidence interval: 0.781–0.989), 78.9%, and 81.8%, respectively. The AUC, sensitivity, and specificity of the clinical model and clinical-conventional radiological model were 0.751 (0.603–0.900), 63.2%, and 63.6%, 0.801 (0.661–0.942), 73.7%, and 68.2%, respectively. A decision curve analysis demonstrated that when the threshold probability was > 20%, the clinical-radiomics model or nomogram may be more advantageous than the treat all or treat-none strategy.ConclusionsThe clinical-radiomics model and nomogram can potentially identify multimodality therapy candidates in patients with early-stage cervical cancer.Key Points• Pretreatment identification of multimodality therapy candidates among patients with early-stage cervical cancer helped to select the optimal primary treatment and reduce severe complication risk and costs.• The clinical-radiomics model achieved a better prediction performance compared with the clinical model and the clinical-conventional radiological model.• An easy-to-use nomogram exhibited good performance for individual preoperative prediction.

MRI-based radiomics features for the non-invasive prediction of FIGO stage in cervical carcinoma: A multi-center study

MRI-based radiomics analysis to evaluate the clinicopathological characteristics of cervical carcinoma: a multicenter study

Radiomics analysis based on multiparametric magnetic resonance imaging for differentiating early stage of cervical cancer

Radiomic Score as a Potential Imaging Biomarker for Predicting Survival in Patients With Cervical Cancer

Classifying early stages of cervical cancer with MRI-based radiomics

Building CT Radiomics-Based Models for Preoperatively Predicting Malignant Potential and Mitotic Count of Gastrointestinal Stromal Tumors

MRI-based radiomics analysis improves preoperative diagnostic performance for the depth of stromal invasion in patients with early stage cervical cancer

Feasibility of MRI-based Radiomics Features for Predicting Lymph Node Metastases and VEGF Expression in Cervical Cancer.

A MRI radiomics-based model for prediction of pelvic lymph node metastasis in cervical cancer

MRI-derived radiomics analysis improves the noninvasive pretreatment identification of multimodality therapy candidates with early-stage cervical cancer

Multi-parametric MRI-based Peritumoral Radiomics for Stage IIA and IIB Classification of Cervical Cancer：A Multicenter Study

Reduced Field-of-view DWI‑derived Clinical–radiomics Model for the Prediction of Stage in Cervical Cancer

An MRI-based radiomics signature and clinical characteristics for survival prediction in early-stage cervical cancer

Multi-Parametric Magnetic Resonance Imaging-Based Radiomics Analysis of Cervical Cancer for Preoperative Prediction of Lymphovascular Space Invasion

Predicting Risk Stratification in Early-Stage Endometrial Carcinoma: Significance of Multiparametric MRI Radiomics Model

Multiparametric MRI-based radiomics combined with 3D deep transfer learning to predict cervical stromal invasion in patients with endometrial carcinoma

An interpretable clinical ultrasound-radiomics combined model for diagnosis of stage I cervical cancer

MRI-Based Radiomic Model for Preoperative Risk Stratification in Stage I Endometrial Cancer

Preoperative prediction of parametrial invasion in early-stage cervical cancer with MRI-based radiomics nomogram

An MRI radiomics-based model for the prediction of invasion of the lymphovascular space in patients with cervical cancer

Development and Validation of Radiomics-Based Models for Predicting the Parametrial Invasion in Stage IB1 to IIA2 Cervical Cancer